07:00 , Jun 30, 2003 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Axovan SA Allschwil, Switzerland Technology: GPCR screening and small molecule drug discovery Disease focus: Vascular disease Clinical status: Phase II Founded: April 2000 by Olivier Valdenaire, Thomas Giller, and Actelion AG Corporate partners: Roche ,...
07:00 , Apr 22, 2002 |  BC Extra  |  Financial News

Axovan raises CHF30 million

Axovan (Allschwil, Switzerland) raised CHF30 million ($18 million) in a venture round led by Atlas Venture. Other investors included Heidelberg Innovation; NeoMed; Banque Cantonale Vaudoise Private Equity; New Medical Technologies; Venture Partners; and Genevest. Also,...
07:00 , Apr 22, 2002 |  BioCentury  |  Finance

Ebb & Flow

Investors cleaning the mud off their boots from biotech's first quarter disasters breathed a sigh of relief after Trimeris delivered on one of the key milestones in the second quarter. TRMS announced Thursday that its...